# Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo

> **NCT07069829** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 1400 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07069829
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069829, "Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07069829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*